Ferrari M, Mekkaoui L, Ilca FT, Akbar Z, et al. Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV-2 variants. J Virol 2021 Jul 21:JVI0068521. doi: 10.1128/JVI.00685.
PMID: 34287040